Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1996
10/16/1996CN1133598A Acylated insulin
10/16/1996CN1133597A Peptide capable of inducing immune response against HIV and AIDS preventive or remedy containing the peptide
10/16/1996CN1133595A Mutants of the Rb and P53 genes and uses thereof
10/16/1996CN1133594A Hsv-2 UL26 gene, capsid proteins, immunoassays and protease inhibitors
10/16/1996CN1133564A The Cloning of duffy blood group antigen
10/16/1996CN1133563A Novel tripeptides useful in immune and CNS therapy
10/16/1996CN1133562A Injectable compositions for soft tissue augmentation
10/16/1996CN1033043C Process for preparation of glucuromide glycoside antibiotic A40926
10/16/1996CN1033035C Method for preparing interferon alpha-2 crystals
10/16/1996CN1033034C Method for preparation of crystalline interleukin-4
10/15/1996US5565606 Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
10/15/1996US5565574 Preparation of phenylalanine derivatives bearing a 1,2,4-triazole moiety and their use in peptides
10/15/1996US5565568 Useful in treatment or prevention of a physiological disorder associated with an excess of tachykinins
10/15/1996US5565550 Antibodies to ICAM-2, and fragments thereof
10/15/1996US5565549 Retroviruse, aids
10/15/1996US5565519 Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications
10/15/1996US5565431 Snake venom
10/15/1996US5565430 Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
10/15/1996US5565429 Human leucocyte elastase inhibitors; emphysema; antiarthritic agents; rheumatic diseases
10/15/1996US5565428 Intermittent dosing
10/15/1996US5565427 Stabilized factor VIII preparations
10/15/1996US5565426 Anti-aggregation, inhibtion of blood clotting
10/15/1996US5565425 Viral infection and proliferation inhibitors
10/15/1996US5565424 Vasoactive intestinal peptide antagonists useful as antitumor and anticancer agents
10/15/1996US5565423 Cyclopeptides and their use as absorption promoters when applied to the mucosa
10/15/1996US5565418 Retroviral protease inhibiting compounds
10/15/1996US5565354 For diagnosis and treatment of diseases caused by infection with hepatitis b virus
10/15/1996US5565352 Deubiquitinating enzyme: compositions and methods
10/15/1996US5565351 Reducing the muscle protein loss by reducing proteolysis
10/15/1996US5565338 Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor
10/15/1996US5565336 Nucleic acid molecule which codes a human interleukin mutein with increased activity and having a phenylalanine residue at position 171 replaced by leucine and a leucine residue at position 175 replaced by methionine
10/15/1996US5565335 Adhesion variants
10/15/1996US5565331 Nucleic acids encoding neural axon outgrowth modulators
10/15/1996US5565327 Detecting hyperphosphorylation of kinase substrate
10/15/1996US5565323 Determination of mutations in sequence of mitochrondial cytochrome oxidase genes which indicate presence or risk of alzheimer*s disease
10/15/1996US5565321 Isolating nucleic acid, amplifying nucleic acid derived from cd40 ligand gene, determining nucleotide sequence, comparing to standard, determining if protein is expressed which binds cd40
10/15/1996US5565200 Pharmaceutical preparations derived from korean mistletoe
10/15/1996US5565198 Zona pellucida as a growth stimulant
10/15/1996US5565197 Containing pathogenic bacteria, chlamydia or yeast in environment of transmitted seminal fluids or semen with composition containing haloperoxidase and oxidase in vaginally aceeptable carrier
10/15/1996US5564458 Timing valve for the discontinuous metering of a volume flow
10/15/1996US5564345 Stackable table, table assembly, and tray and table combination
10/15/1996CA2111092C Specifically beta-beta cross-linked hemoglobins and method of preparation
10/15/1996CA2067498C Composition for inducing granulocyte production or b cell production in peripheral blood
10/15/1996CA2040969C Repopulation of macrophages and granulocytes using transforming growth factor-beta
10/15/1996CA1338643C Purification and administration of dna repair enzymes
10/14/1996CA2174025A1 Agents modulating the response of neuronal cells to inhibition by mammalian central nervous system myelin
10/11/1996CA2148851A1 Atp-diphosphohydrolases and process of purification thereof
10/10/1996WO1996031625A1 Polypeptides having a functional domain of interest and methods of identifying and using same
10/10/1996WO1996031618A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
10/10/1996WO1996031617A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996WO1996031607A2 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
10/10/1996WO1996031605A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996WO1996031604A1 Antibodies for the detection of hla-g
10/10/1996WO1996031599A1 Ndf peptides
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031596A1 Bh55 hyaluronidase
10/10/1996WO1996031539A1 Antibodies and their use in cancer therapy and diagnosis
10/10/1996WO1996031537A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
10/10/1996WO1996031536A1 Synthetic calcitonin mimetics
10/10/1996WO1996031534A1 ISOLATED NUCLEIC ACID MOLECULES ENCODING p57KIP2 AND USES OF SAME
10/10/1996WO1996031533A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same
10/10/1996WO1996031532A1 Sugar-modified cytostatics
10/10/1996WO1996031530A1 Novel peptides and remedy for bone diseases containing the same as active ingredient
10/10/1996WO1996031529A1 Peptides and remedy for autoimmune diseases comprising the same
10/10/1996WO1996031526A1 Anti-obesity agents
10/10/1996WO1996031525A2 Inhibitors of farnesyl-protein transferase
10/10/1996WO1996031504A1 Thrombin inhibitors
10/10/1996WO1996031245A1 Autologous fibrin glue and methods for its preparation and use
10/10/1996WO1996031242A1 RECOMBINANT β-CELL AND USES THEREOF
10/10/1996WO1996031241A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996WO1996031235A1 Composition for inducing a mucosal immune response
10/10/1996WO1996031234A1 Combination compositions containing benazepril or benazeprilat and valsartan
10/10/1996WO1996031233A1 Use of gelatinase b and related enzymes to mobilize hematopoietic stem cells for blood stem cell transplantation
10/10/1996WO1996031231A1 Controlled release biodegradable nanoparticles containing insulin
10/10/1996WO1996031230A1 Medicinal composition for curing thrombocytopenia
10/10/1996WO1996031229A1 Inhibiting rejection of a graft
10/10/1996WO1996031228A1 Cyclic peptide antifungal agents
10/10/1996WO1996031227A1 Phosphonates, biphosphonates and pharmaceutical compositions containing them
10/10/1996WO1996031224A1 Immunosuppressant
10/10/1996WO1996031220A1 Cyclodextrin compounds and methods of making and use thereof
10/10/1996WO1996031217A1 Inhibiting retroviral replication
10/10/1996WO1996031215A1 Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
10/10/1996WO1996031214A1 2-acylaminopropanamides as tachykinin receptor antagonists
10/10/1996WO1996031212A1 A method for the treatment of macular degeneration
10/10/1996WO1996031202A1 Controlled release biodegradable micro- and nanospheres containing cyclosporin
10/10/1996WO1996031129A1 Therapeutic food composition and method to diminish blood sugar fluctuations
10/10/1996WO1996026958A3 Eph receptor ligand elf-2
10/10/1996WO1996021730A3 Ribozymes with rna protein binding site
10/10/1996WO1996021416A3 Methods and compositions for treatment of solid tumors in vivo
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996WO1996016175A3 Lgmd gene coding for a calcium dependent protease
10/10/1996WO1996012737A3 Compositions and treatment for multiple sclerosis
10/10/1996WO1996001430A3 Screening for nuc inhibitors
10/10/1996DE19518488C1 Autoantigen, geeignet zur Feststellung einer Thromboseneigung Autoantigen, suitable for detection of thrombosis
10/10/1996DE19512463A1 Gene and cDNA encoding human cytokine HCC-1
10/10/1996CA2217697A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996CA2217652A1 Recombinant .beta.-cell and uses thereof
10/10/1996CA2217641A1 Polypeptides having a functional domain of interest and methods of identifying and using same
10/10/1996CA2217572A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
10/10/1996CA2217461A1 2-acylaminopropanamides as tachykinin receptor antagonists
1 ... 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 ... 3163